Sify.com » Topics » Piramal Healthcare
Piramal Healthcare News
Piramal Health looks at buyout for expansion
In talks with global players to acquire contract research facilities, critical care biz Piramal Healthcare, sitting on a huge pile of cash after selling its main business to Abbott, is set to strengthen its global presence in contract research and manufacturing services (CRAMS) and critical care business through the acquisition route. The company is engaged in talks with a clutch of global players
In talks with global players to acquire contract research facilities, critical care biz Piramal Healthcare, sitting on a huge pile of cash after selling its main business to Abbott, is set to strengthen its global presence in contract research and manufacturing services (CRAMS) and critical care business through the acquisition route. The company is engaged in talks with a clutch of global players
Nutraceuticals: Riding the healthy living wave
FMCG, Pharma majors eye a bigger share of the growing dietary supplement market
FMCG, Pharma majors eye a bigger share of the growing dietary supplement market
Execution risks could mar prospects
While its existing pharma business is likely to perform well, the company’s move into financial services and the drug discovery space could put pressure on margins in the medium term.
While its existing pharma business is likely to perform well, the company’s move into financial services and the drug discovery space could put pressure on margins in the medium term.
Piramal Health enters financial services space
Piramal Healthcare Ltd (PHL), owned by Ajay Piramal, has entered into the financial services sector by announcing plans to launch two non-banking finance companies (NBFCs). The company has also
Piramal Healthcare Ltd (PHL), owned by Ajay Piramal, has entered into the financial services sector by announcing plans to launch two non-banking finance companies (NBFCs). The company has also
Piramal Life board meet May 6 on demerger of unit
Piramal Life Sciences Ltd said on Wednesday its board will meet on May 6 to consider a proposal for demerger of the new chemical entity research unit into Piramal Healthcare Ltd.
Piramal Life Sciences Ltd said on Wednesday its board will meet on May 6 to consider a proposal for demerger of the new chemical entity research unit into Piramal Healthcare Ltd.
NPPA fixes price of Abbott's epilepsy drug
National Pharmaceutical Pricing Authority (NPPA) has invoked the public interest clause in the Drugs Price Control Order to fix the price of an epileptic drug of Abbott Healthcare, the wholly owned
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise